Jury Clears Armistice Capital, Execs Of Securities Fraud
law360
2 months ago
44 views
A California federal jury on Tuesday cleared Armistice Capital and two of its executives on class action claims it pumped and dumped $250 million in Vaxart stock during the COVID-19 pandemic and violated federal securities law with insider trading.
Continue Reading
Sign up for FREE to read the full article and access 131K+ alternative investment headlines.